Amelia Gentleman: Bombarded with abuse and with its reputation tarnished, Atos has bought its way out of its £400m state contract to assess if benefit claimants are fit to work. A new company, Maximus, is taking over. Who is behind it – and will they do anything differently?
The ex-Ukip candidate Kerry Smith claimed that he made offensive remarks due to stress and the fact that he was taking strong sedatives. So should pharmaceutical companies issue new side-effects warnings, asks Emine Saner
The young anti-FGM campaigner who told David Cameron to ‘grow a pair’ has helped to get the issue on the political agenda this year, writes Corinne Jones